Skyrocketing 108% since the start of 2025, Tempus AI (NASDAQ: TEM), a company applying AI solutions to healthcare, has seen its stock perform exceptionally well this year. Investors have found the ...

The Specter 2 has a full-Pebax midsole, 37mm stack height, and the brand’s signature roomy toebox. Amanda is a test editor at Runner’s World who has run the Boston Marathon every year since ...

Popular investor Cathie Wood and her Ark Invest funds took advantage of a buying opportunity on Tuesday by purchasing over 400,000 shares of Tempus AI (TEM) as the stock plummeted 15%. This move ...

Tempus AI Inc (TEM) reported its fourth-quarter earnings for 2024, showcasing robust revenue growth but a decline in stock price during after-hours trading. The company posted a revenue of $700 ...

Some eight years since the Nintendo Switch was released, we have finally got an official look at the Nintendo Switch 2. In a rather brief trailer, Nintendo showed off its next-generation gaming ...

The financing is intended to support Tempus’ previously announced acquisition of Ambry Genetics ("Ambry"), which closed on February 3, 2025. Combined with $260 million of capital provided in ...

TEM also has other innovative assets like xT CDx, xH tests, and enhanced Tempus One that I think position ... their $600 million acquisition of Ambry Genetics, and 2) the launch of its app ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will participate in the Morgan Stanley Technology, Media & Telecom ...